Beer TM, Pierce WC, Lowe BA, Henner WD. Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer. Ann Oncol. 2001;12(9):1273-1279.
3.
Havranek EG, Whelan MA, Greenhalgh R., Dalgleish AG, Pandha H.Advances in prostate cancer immunotherapy. Surg Oncol. 2002;11(1-2):35-45.
4.
Reese DMNew agents for prostate cancer. Hematol Oncol Clin North Am . 2001;15:547-557.
5.
Block KIDiet and quality and quantity of life in cancer patients. In: Adjuvant Nutrition in Cancer Treatment Proceedings, Symposium on Adjuvant Nutrition in Cancer Treatment. Tulsa, Okla: Cancer Treatment Centers of America; 1993.
6.
Yatani R., Chigus I., Akazaki K., Stemmerman GN, Welsh RA, Correa P.Geographic pathology of latent prostatic carcinoma. Int J Cancer. 1982;29:611-616.
7.
Grotto D.Integrative tumor board: recently diagnosed lung cancer. Nutritional assessment and recommendations. Integrative Cancer Therapies. 2002;1(3):255-259.
8.
Liu J., Burdette JE, Xu H., et al. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem . 2001;49(5):2472-2479.
9.
Cordell GAPC-SPES: a brief overview. Integrative Cancer Therapies. 2002;1(3):271-286.
10.
Blumenthal M.Guest editorial. The rise and fall of PC-SPES: new generation of herbal supplement, adulterated product, or new drug?Integrative Cancer Therapies. 2002;1(3):266-270.
11.
Wannamethee SG, Shaper AG, Walker M.Physical activity and risk of cancer in middle-aged men. Br J Cancer. 2001;85(9): 1311-1316.
12.
Gann PH, Hennekens CH, Sacks FM, Grodstein F., Giovanucci EL, Stampfer MJProspective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst. 1994;86(4):281-286.
13.
Newcomer LM, King IB, Wicklund KG, Stanford JLThe association of fatty acids with prostate cancer risk. Prostate. 2001;47(4):262-268.
14.
Freeman VL, Meydani M., Yong S., et al. Prostatic levels of fatty acids and the histopathology of localized prostate cancer. J Urol. 2000;164(6):2168-2172.
15.
Lin X., Gingrich JR, Bao W., Lao J., Haroon ZA, Demark-Wahnefried W.Effect of flaxseed supplementation on prostatic carcinoma in transgenic mice . Urology. 2002;60(5):919-924.
16.
Demark-Wahnefried W., Price DT, Polascik TJ, et al. Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology. 2001;58(1):47-52.
17.
Cunningham AJ, Phillips C., Lockwood GA, Hedley DW, Edmonds CVAssociation of involvement in psychological self-regulation with longer survival in patients with metastatic cancer: an exploratory study. Adv Mind Body Med. 2000 ;16(4): 276-287.